Sg Americas Securities, LLC Karuna Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$161.01 - $317.85 $27 Million - $53.2 Million	167,448 Added 2482.55%	174,193 $55.1 Million
Q3 2023 Oct 13, 2023	BUY	$164.66 - $218.08 $951,570 - $1.26 Million	5,779 Added 598.24%	6,745 $1.14 Million
Q2 2023 Jul 10, 2023	SELL	$176.32 - $240.22 $1.39 Million - $1.89 Million	-7,862 Reduced 89.06%	966 $209,000
Q1 2023 Apr 28, 2023	BUY	$161.33 - $204.36 $197,951 - $250,749	1,227 Added 16.14%	8,828 $1.6 Million
Q4 2022 Feb 02, 2023	BUY	$191.53 - $236.82 $92,508 - $114,384	483 Added 6.79%	7,601 $1.49 Million
Q3 2022 Oct 31, 2022	SELL	$123.79 - $277.42 $1.62 Million - $3.62 Million	-13,054 Reduced 64.71%	7,118 $1.6 Million
Q2 2022 Jul 29, 2022	BUY	$93.97 - $143.33 $1.11 Million - $1.69 Million	11,785 Added 140.52%	20,172 $2.55 Million
Q1 2022 Apr 29, 2022	SELL	$98.9 - $132.37 $251,008 - $335,955	-2,538 Reduced 23.23%	8,387 $1.06 Million
Q4 2021 Feb 07, 2022	BUY	$110.64 - $159.4 $530,629 - $764,482	4,796 Added 78.25%	10,925 $1.43 Million
Q3 2021 Nov 01, 2021	BUY	$101.2 - $125.87 $283,461 - $352,561	2,801 Added 84.16%	6,129 $750,000
Q2 2021 Aug 12, 2021	SELL	$107.45 - $135.95 $231,554 - $292,972	-2,155 Reduced 39.3%	3,328 $379,000
Q1 2021 May 13, 2021	SELL	$95.46 - $133.08 $4.49 Million - $6.26 Million	-47,062 Reduced 89.57%	5,483 $659,000
Q4 2020 Feb 04, 2021	BUY	$75.23 - $109.23 $1.51 Million - $2.19 Million	20,046 Added 61.68%	52,545 $5.34 Million
Q3 2020 Nov 09, 2020	BUY	$71.31 - $109.74 $1.72 Million - $2.65 Million	24,148 Added 289.16%	32,499 $2.51 Million
Q2 2020 Jul 20, 2020	BUY	$62.14 - $117.21 $273,353 - $515,606	4,399 Added 111.31%	8,351 $931,000
Q1 2020 Apr 30, 2020	BUY	$60.41 - $115.92 $238,740 - $458,115	3,952 New	3,952 $285,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account